The Effect of Dapagliflozin on Patients With Cardiomyopathy

This study is testing whether dapagliflozin — a drug commonly used for diabetes and heart failure — can benefit patients hospitalized with acute heart failure, regardless of whether they have diabetes or what type of heart failure they have. **You may be eligible if...** - You are 18 years or older - You are hospitalized or visiting an emergency department for acute heart failure with typical symptoms - Your natriuretic peptide levels (a heart stress marker) are elevated - You are planned to receive intravenous diuretics (water pills) as part of your treatment **You may NOT be eligible if...** - You have type 1 diabetes - You have a urinary tract or genital infection - You are severely dehydrated (hypovolemia) - You have diabetic ketoacidosis - Your blood glucose is below 80 mg/dL or blood pressure is below 90 mmHg at enrollment - You have a known allergy to any SGLT2 inhibitor drug Talk to your doctor to see if this trial is right for you.